Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

CKS Updates - January 2019

During January 2019 Clinical Knowledge Summaries were published or updated in the following areas.

The majority of topics have undergone reviews and minor restructures. The most significant changes are to the Depression - antenatal and postnatal topic where a section on prevalence has been added and management recommendations have been updated in line with the NICE, the Febrile seizure topic where Assessment and Differential diagnosis sections have been added and management recommendations have been updated in line with current literature and the two Feverish children topics where a section on Prevalence and management recommendations have been updated in line with current literature.

Action: Clinicians who see patients with any of these conditions may find the new and updated information useful when reviewing current clinical practice.

Share 'CKS Updates - January 2019' on Email Share 'CKS Updates - January 2019' on Delicious Share 'CKS Updates - January 2019' on Digg Share 'CKS Updates - January 2019' on Facebook Share 'CKS Updates - January 2019' on reddit Share 'CKS Updates - January 2019' on StumbleUpon Share 'CKS Updates - January 2019' on Twitter

NICE Guidance - January 2019

The National Institute of Health and Care Excellence (NICE) have published new or updated guidance for the month of January 2019. This month there are two guidelines that impact upon primary care.

The Renal and ureteric stones guideline has been published. It covers assessing and managing renal and ureteric stones. It aims to improve the detection, clearance and prevention of stones, so reducing pain and anxiety, and improving quality of life.

The Cerebral palsy in adults guideline has been published. It covers care and support for adults with cerebral palsy. It aims to improve health and wellbeing, promote access to services and support participation and independent living.

Action: Clinicians should be aware of this month's new guidance and implement any necessary changes to practice.

Share 'NICE Guidance - January 2019' on Email Share 'NICE Guidance - January 2019' on Delicious Share 'NICE Guidance - January 2019' on Digg Share 'NICE Guidance - January 2019' on Facebook Share 'NICE Guidance - January 2019' on reddit Share 'NICE Guidance - January 2019' on StumbleUpon Share 'NICE Guidance - January 2019' on Twitter

SMC Update - January 2019

The Scottish Medicines Consortium (SMC) has issued its monthly advice on newly licensed medicines.

Tiotropium (Spiriva Respimat®) has been accepted for use as add-on maintenance bronchodilator treatment in patients aged 6 years and older with severe asthma who experienced one or more severe asthma exacerbations in the preceding year.

Ertugliflozin (Steglatro®) has been accepted for restricted use in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:

  • As monotherapy in patients for whom the use of metformin is considered inappropriate due to intolerance or contraindication.
  • In addition to other medicinal products for the treatment of diabetes

The restriction limits use as monotherapy to patients who would otherwise receive a dipeptidyl peptidase-4 inhibitor and in whom a sulphonylurea or pioglitazone is not appropriate.

Semaglutide (Ozempic®) has been accepted for restricted use in the treatment of adults with insufficiently controlled type 2 diabetes mellitus (T2DM) as an adjunct to diet and exercise when used in addition to other medicinal products for the treatment of diabetes. The restriction limits this drug to add on use only as the submission from the manufacturer did not relate to use as monotherapy when metformin is considered inappropriate.

Action: Clinicians should be aware of the recommendations of the SMC. Routine use of rejected and restricted medicines should be avoided.

Share 'SMC Update - January 2019' on Email Share 'SMC Update - January 2019' on Delicious Share 'SMC Update - January 2019' on Digg Share 'SMC Update - January 2019' on Facebook Share 'SMC Update - January 2019' on reddit Share 'SMC Update - January 2019' on StumbleUpon Share 'SMC Update - January 2019' on Twitter

Antiviral Medicines Authorised for Influenza Season 2018/19

The Department of Health has written to healthcare professionals via the Central Alerting System (PDF) to advise that antiviral medicines may now be prescribed at NHS expense due to rising levels in reporting of influenza-like illness.

Surveillance data indicates an increase in influenza cases in the community and as such GPs and other prescribers working in primary care may now prescribe antiviral medicines for the prophylaxis and treatment of influenza. Doses and treatment schedules are contained in existing Public Health England guidance.

Clinicians should remember to endorse the prescription with 'SLS' to ensure that it can be dispensed in community pharmacies without undue delay.

Action: Clinicians should be aware of this letter and familiarise themselves with the current prescribing guidance.

Share 'Antiviral Medicines Authorised for Influenza Season 2018/19' on Email Share 'Antiviral Medicines Authorised for Influenza Season 2018/19' on Delicious Share 'Antiviral Medicines Authorised for Influenza Season 2018/19' on Digg Share 'Antiviral Medicines Authorised for Influenza Season 2018/19' on Facebook Share 'Antiviral Medicines Authorised for Influenza Season 2018/19' on reddit Share 'Antiviral Medicines Authorised for Influenza Season 2018/19' on StumbleUpon Share 'Antiviral Medicines Authorised for Influenza Season 2018/19' on Twitter

NICE Guidance - December 2018

The National Institute of Health and Care Excellence (NICE) have published new or updated guidance for the month of December 2018. This month there are five guidelines that impact upon primary care.

The Antenatal care for uncomplicated pregnancies guideline has been updated. The recommendations on alcohol consumption in pregnancy have been removed and replaced by a link to the UK CMOs' low-risk drinking guidelines.

The Post-traumatic stress disorder guideline has been published and replaces prior guidance from 2005. It covers recognising, assessing and treating post-traumatic stress disorder (PTSD) in children, young people and adults. It aims to improve quality of life by reducing symptoms of PTSD such as anxiety, sleep problems and difficulties with concentration. Recommendations also aim to raise awareness of the condition and improve coordination of care.

The Chronic obstructive pulmonary disease in over 16s guideline has been published and replaces prior guidance from June 2010. It covers diagnosing and managing chronic obstructive pulmonary disease (COPD) in people aged 16 and older, which includes emphysema and chronic bronchitis. It aims to help people with COPD to receive a diagnosis earlier so that they can benefit from treatments to reduce symptoms, improve quality of life and keep them healthy for longer.

The Chronic obstructive pulmonary disease (acute exacerbation): antimicrobial prescribing guideline has been published. It sets out an antimicrobial prescribing strategy for acute exacerbations of chronic obstructive pulmonary disease (COPD). It aims to optimise antibiotic use and reduce antibiotic resistance.

The Bronchiectasis (non-cystic fibrosis), acute exacerbation: antimicrobial prescribing guideline has been published. It sets out an antimicrobial prescribing strategy for managing and preventing acute exacerbations of bronchiectasis (non-cystic fibrosis). It aims to optimise antibiotic use and reduce antibiotic resistance.

Action: Clinicians should be aware of this month's new guidance and implement any necessary changes to practice.

Share 'NICE Guidance - December 2018' on Email Share 'NICE Guidance - December 2018' on Delicious Share 'NICE Guidance - December 2018' on Digg Share 'NICE Guidance - December 2018' on Facebook Share 'NICE Guidance - December 2018' on reddit Share 'NICE Guidance - December 2018' on StumbleUpon Share 'NICE Guidance - December 2018' on Twitter

« Older Posts

Prescribing Advice for GPs is powered by ClassicPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.

atomic-wealth
fond-illness
summer